openPR Logo
Press release

Global Peptides and Heparin Market Poised for Rapid Surge at a CAGR of 8.10% by 2026

02-15-2018 09:06 AM CET | Health & Medicine

Press release from: Fact.MR

Fact.MR

Fact.MR

According to Fact.MR, the global peptide and heparin market is projected to reflect a high single-digit CAGR throughout the forecast period (2017-2026). The market is estimated to reach nearly US$ 35,000 Mn revenues by 2026-end.

Request For Sample Report @https://www.factmr.com/connectus/sample?flag=S&rep_id=378

The scope of Fact.MR’s report is to analyze the global peptide and heparin market for the forecast period 2017-2022 and provide readers an unbiased and accurate analysis. Medical device manufacturers, research institutes, and raw material suppliers in the global peptide and heparin market can benefit from the analysis offered in this report. This report offers a comprehensive analysis, which can be of interest to leading trade magazines and medical journals pertaining to peptide and heparin.

Key Future Prospects of Peptide and Heparin Market for Forecast Period 2017-2026

1) Hospital pharmacies are expected to remain the dominant distribution channel for peptide and heparin. Revenues from sales of peptide and heparin in hospital pharmacies are anticipated to remain considerably larger than those from retail pharmacies and online pharmacies combined.

2) On the basis of indication, revenues from sales of peptide and heparin for cancer treatment are projected to account for the largest market share by 2026-end. Cardiovascular and metabolic disorder indication will also remain remunerative in the market. Sales of peptide and heparin for central nervous systems indication are expected to register the fastest expansion through 2026.

3) Oral route of administration will remain preferred for peptide and heparin, with revenues estimated to surpass US$ 15,000 Mn by 2026-end. However, sales of peptide and heparin with intravenous route of administration will register a comparatively faster growth through 2026.

4) Liraglutide is expected to remain the most lucrative product in the market, followed by bortezomib and goserelin. Liraglutide sales will exhibit the highest CAGR through 2026. In addition, sales of sodium heparin, lithium heparin and exenatide are projected to register a parallel growth through 2026.

5) Asia-Pacific excluding Japan (APEJ) will continue to be the largest market for peptide and heparin, in terms of revenues. The markets in Europe and North America will also remain lucrative, however revenues from these regions will remain significantly lower than those from APEJ.

Browse Full Report with TOC @https://www.factmr.com/report/378/peptides-heparin-market

APEJ to Remain Most Remunerative Market for Peptide and Heparin

There has been a growing demand for new oral anticoagulants having better efficacy and safety profiles in Asia-Pacific excluding Japan (APEJ). Side effects related to heparin products, including complications of bleeding and heparin-induced thrombocytopenia has resulted into robust adoption of oral anticoagulants in the region. In addition, rising incidence of cancer, metabolic disorders, and hepatitis, along with advancements in peptide synthesis technology and rapid demand for various peptide therapies in the region are expected to drive the growth in APEJ. APEJ will remain the most remunerative market for peptide and heparin.

Liraglutide and ammonium heparin are expected to remain fast-expanding products in the market. In addition, sales of exenatide, lithium heparin, and sodium heparin will register a similar CAGR through 2026.

Competition Tracking

The global market for peptide and heparin is high fragmented and competitive owing to the presence of a large number of international and regional vendors. These vendors are continuously focusing on the development of generic formulations related to blood coagulation and several other novel therapeutic areas. Companies having the capability of manufacturing drugs for effective treatment of coagulation disorders, along with high efficacy and safety profiles are likely to gain maximum market shares in the foreseeable future. Key market participants identified by the report include Baxter, Celsus, Biofer S.p.A,, Hemmo Pharma, AmbioPharm, Inc., Wockhardt Ltd., Sun Pharmaceutical Industries Ltd., Bachem, Abbott Laboratories, Pfizer Inc., Aspen, Leo Pharma, Teva, Takeda, Sanofi, Novo Nordisk, and Eli Lilly.

Check Discount @https://www.factmr.com/connectus/sample?flag=D&rep_id=378

About Fact.MR

Fact.MR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market research reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.

Contact Us

Fact.MR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Peptides and Heparin Market Poised for Rapid Surge at a CAGR of 8.10% by 2026 here

News-ID: 944370 • Views:

More Releases from Fact.MR

Fumaric Acid Market Forecast CAGR of 6.8% Predicted for 2023-2033 with a US$ 969.0 Million
Fumaric Acid Market Forecast CAGR of 6.8% Predicted for 2023-2033 with a US$ 969 …
In 2023, the fumaric acid market (フマル酸市場) reached a value of US$ 501.9 million, with projections indicating a growth at a CAGR of 6.8% to attain US$ 969.0 million by 2033. Fumaric acid, a key component in various industries including food and beverage, pharmaceuticals, and chemicals, is witnessing a steady rise in demand due to its versatile applications. The growth of the fumaric acid market is primarily driven by the
Buffering Agents Market Set for 5.1% CAGR Through 2023-2033 with a US$ 226.8 Million
Buffering Agents Market Set for 5.1% CAGR Through 2023-2033 with a US$ 226.8 Mil …
The buffering agents market (緩衝剤市場) is projected to reach a valuation of US$ 226.8 million by 2033, with a compound annual growth rate (CAGR) of 5.1% from 2023 to 2033. In 2023, the industry was valued at US$ 137.9 million. The market for buffering agents is anticipated to witness significant growth driven by increased industrial applications, expansion in the pharmaceutical and healthcare sectors, and rising demand for processed food and beverages.
Patient Temperature Monitoring Market Overview: Reaching US$ 8.2 Billion by 2026
04-23-2024 | Health & Medicine
Fact.MR
Patient Temperature Monitoring Market Overview: Reaching US$ 8.2 Billion by 2026
According to Fact.MR, a market research and competitive intelligence provider, the Global Patient Temperature Monitoring Market is predicted to reach a size of US$ 8.2 billion by 2026, rising at a CAGR of 10% from 2022 to 2026. a patient temperature monitor is a portable gadget that can measure temperature on its own for a brief amount of time. Opportunities for market participants will arise from the large patient pool
Surgical Equipment Market 8.6% CAGR: The Path to US$ 38.1 Billion By 2033
04-23-2024 | Health & Medicine
Fact.MR
Surgical Equipment Market 8.6% CAGR: The Path to US$ 38.1 Billion By 2033
Fact.MR's global Surgical Equipment Market research study provides a thorough examination of the top market segments according to application, region, business size, solution, and module. It also offers in-depth details on important participants and the primary strategies used to obtain an advantage over rivals. Fact.MR: A Supplier of Competitive Intelligence and Market Research: The surgical equipment market is expected to grow at a remarkable 8.6% CAGR over the following ten

All 5 Releases


More Releases for APEJ

Dimethylolpropionic Acid (DMPA) Market: APEJ to Remain Largest Consuming
Future Market Insights (FMI) delivers key insights on the global dimethylolpropionic acid market in its upcoming report titled “Dimethylolpropionic Acid (DMPA) Market: Global Industry Analysis and Opportunity Assessment 2015–2020”. The global Dimethylolpropionic Acid (DMPA) market is projected to expand at a CAGR of over 8% during the forecast period (2015–2020), largely due to increasing demand for polyurethane dispersions, regarding which FMI offers vital insights in detail in this report. On the
Ginger Market: APEJ to Present Attractive Growth Opportunities
The global ginger market is characterized by the presence of a large pool of established players, and therefore the market’s vendor landscape is fragmented and competitive in nature. The players are making use of new flavours in order to attract more customers and introducing new products with added nutrients, notes Transparency Market Research (TMR) in its report on the global ginger market. Some of the players within the market which
Card Printing Ribbon Market APEJ to Spearhead
According to a new study by Transparency Market Research (TMR), the business landscape in the global card printing ribbon market is highly competitive. Zebra Technologies, Entrust Datacard Corp., IdentiSys Inc., HID Global Corp., Evolis SA, NBS Technologies Inc., AlphaCard, Unicard Systems Pty. Ltd., Dai Nippon Printing Co. Ltd., and Idp Corp. are some of the leading players in this market. They are likely to focus on mergers and acquisitions in
Rigid Food Containers Market APEJ to Remain Largest
The global rigid food containers market is projected to register a moderate 4 % CAGR throughout the forecast period (2017-2022), according to a new study by Future Market Insights (FMI). The report estimates the global rigid food containers market to surpass revenues worth US$ 80,000 Mn by 2022-end. Key Takeaways from FMI’s Report on Global Rigid Food Containers Market Rigid food containers will continue to find the largest applications in ready-to-eat food
Shrimp Market APEJ to Dominate the Global
Future Market Insights’ new report titled “Shrimp Market: Global Industry Analysis (2012-2016) and Opportunity Assessment (2017-2027)” studies the overall performance of the highly competitive global shrimp market for the assessment period of 10 years. The global shrimp market is anticipated to expand at a significant CAGR over the forecast period and APEJ is likely to dominate the market by grabbing maximum revenue share during the assessed 10 year period. Revenue from
Aquafeed Market APEJ to Remain Dominant in Regional
A US$ 50 Bn market, the global aquafeed market has been largely concentrated in the APEJ region for over two decades, owing to a large supply of fresh water in the region and a thriving aquaculture market. While North America will continue to witness significant growth during the forecast period, the MEA market is slated to display great potential in the coming years, owing to a cheap labour force and